Tenax Therapeutics (TENX) Net Margin (2010 - 2015)

Name: Tenax Therapeutics (TENX) Net Margin (2010 - 2015) | Business Quant
Creator: Business Quant

Tenax Therapeutics recorded quarterly Net Margin of 9877.81% in Q2 2015, down 736.66% quarter-over-quarter from 1551.5% in Q2 2013.

Tenax Therapeutics' Net Margin history runs 5 years deep, the most recent figure standing at 9877.81% for Q2 2015.

In Q2 2015, Net Margin changed N/A year-over-year to 9877.81%; the TTM figure through Jun 2016 stood at 12031.27% (up 1241210.0% YoY), while the FY2015 annual figure was 6953.21%, changed N/A from the prior year.
Net Margin came in at 9877.81% for Q2 2015 at Tenax Therapeutics, down from 1551.5% in the prior quarter.
In the past five years, Net Margin ranged from a high of 10522.58% in Q1 2011 to a low of 11513.99% in Q3 2011.
A 4-year average of 1009.57% and a median of 302.46% in 2012 frame the typical range for Net Margin.
On a YoY basis, Net Margin climbed as much as 1283211 bps in 2012 and fell as far as 1546146 bps in 2012.
Tenax Therapeutics' Net Margin stood at 3074.85% in 2011, then soared by 110 bps to 302.46% in 2012, then jumped by 413 bps to 1551.5% in 2013, then plunged by 737 bps to 9877.81% in 2015.
According to Business Quant data, Net Margin over the past three periods registered 9877.81%, 1551.5%, and 1091.58% for Q2 2015, Q2 2013, and Q1 2013 respectively.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	0.82%
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	34.53%
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	20.17%
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	17.65%
10	Tenax Therapeutics	542.72 Mn	542.72 Mn	-	-

Download Data 🔒